Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Goal-directed neuroprotection bundle for adults after cardiac arrest

Official title: A Multicenter, Prospective, Stepped Wedge Cluster Randomized Controlled Study on the Effect of Neuroprotection Bundles on the Improvement of Neurological Outcomes After Cardiopulmonary Resuscitation

Run by Xiangya Hospital of Central South University · NCT06992843 · Data updated 2026-11-12

This trial will test whether a goal-directed bundle of treatments (temperature, breathing gases, position, blood pressure, glucose, sodium and lactate control) helps adults who are unconscious after return of circulation from cardiac arrest recover their brain function better than usual care.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment1008 (estimated)
SponsorXiangya Hospital of Central South University
Academic / other
Locations1 site (Changsha, Hunan)
StatusRecruiting
StartedOctober 22, 2025
Main results expectedAugust 2027
Study endsAugust 2027
Registry record updatedNovember 18, 2025
Trial IDNCT06992843 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 to 79 who achieve return of spontaneous circulation after cardiac arrest, remain unconscious (FOUR motor score <4 or GCS ≤8), and can be enrolled within the trial's acute time windows are ideal candidates.

Probably not a fit

Patients who regained consciousness immediately after ROSC, had unwitnessed or prolonged arrests, had ROSC beyond the allowed time windows, had end-stage disease, or had cardiac arrest from a primary neurologic cause are unlikely to benefit from enrollment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

LAPTOPS is a pragmatic interventional trial that randomizes adult patients who remain unconscious after return of spontaneous circulation following in- or out-of-hospital cardiac arrest to either a goal-directed neuroprotection care bundle or usual care. The bundle targets body temperature, PaCO2, PaO2, patient positioning, blood glucose, sodium, blood pressure and lactate levels during the acute post-arrest phase. The trial enrolls adults aged 18–79 who achieve ROSC within prespecified time windows and whose surrogates provide consent. Clinical and neurological recovery outcomes are compared between groups to determine whether a standardized bundle improves recovery in routine care settings.

Why it matters

Potential benefit: If successful, the bundle could improve neurological recovery and survival after cardiac arrest by standardizing acute neuroprotective management.

How similar studies have gone: Individual elements such as targeted temperature management and blood pressure/oxygen control have shown mixed benefits in prior work, but combining them into a standardized goal-directed bundle is less well tested and remains novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years and \< 80 years
* Patients of in-hospital or out-of-hospital cardiac arrest who have returned -spontaneous circulation (ROSC) after cardiopulmonary resuscitation and do not require CPR for more than 20 minutes;
* Patients who are unconscious after ROSC, defined as FOUR motor response score \< 4 points or GSC ≤ 8 points;
* Family members or legal representatives signed informed consent.

Exclusion Criteria:

* Unwitnessed cardiac arrest, estimated time from cardiac arrest to start of CPR \> 30 minutes;
* Time from cardiac arrest to ROSC \> 60 minutes;
* Patients who woke up immediately after ROSC by CPR;
* End-stage diseases;
* Cardiac arrest considered to be caused by neurological diseases;
* The patient was in a vegetative state before cardiac arrest;
* The interval from the onset of cardiac arrest to enrollment is \>72 hours .

Where it's running

  • Xiangya hospital,Central South University
    Changsha, Hunan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.